These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1774268)

  • 1. Evidence for long-term memory of the mucosal immune system: milk secretory immunoglobulin A against Shigella lipopolysaccharides.
    Hayani KC; Guerrero ML; Ruiz-Palacios GM; Gomez HF; Cleary TG
    J Clin Microbiol; 1991 Nov; 29(11):2599-603. PubMed ID: 1774268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
    Hayani KC; Guerrero ML; Morrow AL; Gomez HF; Winsor DK; Ruiz-Palacios GM; Cleary TG
    J Pediatr; 1992 Dec; 121(6):852-6. PubMed ID: 1447644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
    Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human milk secretory immunoglobulin A to Shigella virulence plasmid-coded antigens.
    Cleary TG; West MS; Ruiz-Palacios G; Winsor DK; Calva JJ; Guerrero ML; Van R
    J Pediatr; 1991 Jan; 118(1):34-8. PubMed ID: 1986095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milk secretory IgA related to Shigella virulence antigens.
    Cleary TG; Hyani K; Winsor DK; Ruiz-Palacios G
    Adv Exp Med Biol; 1991; 310():369-73. PubMed ID: 1809012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
    Chisenga CC; Bosomprah S; Simuyandi M; Mwila-Kazimbaya K; Chilyabanyama ON; Laban NM; Bialik A; Asato V; Meron-Sudai S; Frankel G; Cohen D; Chilengi R
    PLoS One; 2021; 16(5):e0252222. PubMed ID: 34043697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Total and specific IgA in colostrum and milk of mothers of Natal-Rio Grande do Norte, Brasil].
    Araújo ED; Carbonare SB; de Araújo MC; Palmeira P; Amaral JA; Sales VS
    Acta Cir Bras; 2005; 20 Suppl 1():178-84. PubMed ID: 17768806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titres of class-specific antibodies against Shigella and Salmonella lipopolysaccharide antigens in colostrum and breast milk of Costa Rican, Swedish and Vietnamese mothers.
    Achí R; Dac Cam P; Forsum U; Karlsson K; Sáenz P; Mata L; Lindberg AA
    J Infect; 1992 Jul; 25(1):89-105. PubMed ID: 1522329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides.
    Oberhelman RA; Kopecko DJ; Salazar-Lindo E; Gotuzzo E; Buysse JM; Venkatesan MM; Yi A; Fernandez-Prada C; Guzman M; León-Barúa R
    Infect Immun; 1991 Jul; 59(7):2341-50. PubMed ID: 2050402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
    Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
    J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G.
    Clarkson KA; Frenck RW; Dickey M; Suvarnapunya AE; Chandrasekaran L; Weerts HP; Heaney CD; McNeal M; Detizio K; Parker S; Hoeper A; Bourgeois AL; Porter CK; Venkatesan MM; Kaminski RW
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968012
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
    Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
    Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An immunoenzyme method for determining IgA antibodies to lipopolysaccharide in secretions in the diagnosis of shigellosis].
    Salamatova SA; Sukhoroslova LI; Shalamberidze IA; Brusenina ND
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):85-9. PubMed ID: 8067099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei.
    Orr N; Robin G; Lowell G; Cohen D
    J Clin Microbiol; 1992 Aug; 30(8):2165-8. PubMed ID: 1500527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.
    Orr N; Robin G; Cohen D; Arnon R; Lowell GH
    Infect Immun; 1993 Jun; 61(6):2390-5. PubMed ID: 8500877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
    Taylor DN; Trofa AC; Sadoff J; Chu C; Bryla D; Shiloach J; Cohen D; Ashkenazi S; Lerman Y; Egan W
    Infect Immun; 1993 Sep; 61(9):3678-87. PubMed ID: 8359890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.